Bengaluru, India

Zainuddin Mohd


 

Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):

Title: Inventor Spotlight: Zainuddin Mohd

Introduction: Zainuddin Mohd, based in Bengaluru, India, is a notable inventor in the field of medicinal chemistry. With a focus on innovative solutions for complex health challenges, he has made significant contributions through his research and patent holdings. His work is primarily centered on the development of compounds that inhibit protein arginine methyltransferase 5 (PRMT5), which is relevant in treating various serious health conditions.

Latest Patents: Zainuddin holds a patent titled "Heterocyclic compounds as PRMT5 inhibitors." This patent describes a range of compounds, including those of Formula I, Formula Ia, and Formula Ib, along with their analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites, and prodrugs. These compounds target PRMT5 and offer therapeutic potential for diseases associated with cellular growth, such as malignant tumors, schizophrenia, Alzheimer’s disease, and Parkinson’s disease.

Career Highlights: Zainuddin currently works at Jubilant Episcribe LLC, where he applies his expertise in drug development and medicinal chemistry. His ability to innovate in the pharmaceutical sector is reflected in his successful patent, demonstrating his dedication to improving human health through scientific advancement.

Collaborations: Throughout his career, Zainuddin has collaborated with esteemed colleagues, including Saravanan Vadivelu and Sridharan Rajagopal. These partnerships highlight the importance of teamwork in advancing research and fostering the development of effective therapeutic solutions.

Conclusion: Zainuddin Mohd is a promising inventor whose work on PRMT5 inhibitors showcases the potential of innovative compounds in treating debilitating diseases. With his patent and ongoing research at Jubilant Episcribe LLC, he continues to contribute significantly to the field of medicinal chemistry, paving the way for future advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…